Home›Companies›Biotech & Pharma›3X Genetics

3X Genetics Inc.

Genetic sequencing services for researchers and trial sponsors studying complex DNA regions.

Updated Nov 10, 2026·Latest SEC filing Mar 25, 2026·Suggest an edit

About 3X Genetics

3X Genetics is a private company based in Worcester, Massachusetts, incorporated in 2021 in Delaware. It has reported $3,159,986 raised in one offering on Form D since March 2026. Its chief executive is Kevin Donahue.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 5, 2024Mar 25, 2026$3,159,986of $4.0M target52$60,769Equity, DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 3X Genetics's Form D filed Mar 25, 2026.

KD
Kevin Donahue
CEO and Co-Founder, director

Sources

  1. SEC3X Genetics Inc. filing history
  2. CompanyAbout 3X Genetics